🔴 Inovio Pharmaceuticals is trading 5.5% down with no confirmed catalyst

Inovio Pharmaceuticals is trading 5.48% lower at $0.95 on October 21, 2026; no specific catalyst for the decline is confirmed.

• On October 20, the company announced an $80,416,101 judgment against VGXI and GeneOne.
• The company cautioned that the defendants’ financial condition could hinder collection of some or all of the award.
• Sector and market context is positive and does not explain the decline.